BioInvent’s BI-1206 could improve treatment in several cancers
Alexander Eggermont, MD, PhD, Chief Scientific Officer at the Princess Máxima Center and renowned expert...
Catalent Biologics to Invest $30 Million to Create European Clinical Manufacturing Center of Excellence...
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...
GSK and CureVac announce strategic mRNA technology collaboration
GlaxoSmithKline plc and CureVac announced the signing of a strategic collaboration agreement for the research,...
CMIC Group Establishes a New Biologic Contract Development and Manufacturing Business in Japan
CMIC HOLDINGS Co., Ltd. announced the establishment of CMIC BIO Co., Ltd. (hereafter CMIC BIO),...
CEPI expands partnership with Clover to rapidly advance development and manufacture of COVID-19 vaccine...
CEPI, the Coalition for Epidemic Preparedness Innovations, announced the expansion of its partnership with Sichuan...
Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement
Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and...
Biophore India gets DCGI nod to manufacture COVID drug Favipiravir API
Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of...
Vetter Further Expands its Development Service with New Site in Austria
With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert...
Vetter and Rentschler Biopharma team up to simplify processes and optimize time-to-market
With drug development growing increasingly complex and cost-intensive, biopharmaceutical companies are under significant pressure to...
CIRION BioPharma Research Expands its Bioanalytical Services and Offers SARS-CoV-2 and COVID-19 Antibodies Testing...
CIRION Research Inc., a leading provider of large molecule bioanalytical testing and global central laboratory...
